Skip to Main Content

Author Details

Michael J Clare-Salzler
University of Florida College of Medicine
1989
143
48
PMIDPaper TitleJournal TitlePublished Year
32726799Predictors of oxylipins in a healthy pediatric population.Pediatr Res2021
33652624Collection and Storage of Human Plasma for Measurement of Oxylipins.Metabolites2021
33893822The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).Diabetologia2021
34189259Pathology Informatics and Robotics Strategies for Improving Efficiency of COVID-19 Pooled Testing.Acad Pathol2021
34213803The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.J Clin Lab Anal2021
33381911Association of Lipid Mediators With Development of Future Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population.Arthritis Rheumatol2021
32284963Informatics Training for Pathology Practice and Research in the Digital Era.Acad Pathol2020
33754137Optimizing COVID-19 testing capabilities and clinical management using pathology informatics.JAMIA Open2020
31119191Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model.ACS Biomater Sci Eng2019
31572748Vitamin D and Omega 3 Field Study on Progression of Type 1 Diabetes.CellR4 Repair Replace Regen Reprogram2019
31514368Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes.Nutrients2019
29351371Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned.Clin Transl Sci2018
29894743Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection.Clin Immunol2018
29535047Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trial.Contemp Clin Trials2018
29651443Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.J Immunol Res2018
29102571Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.JACC Cardiovasc Interv2018
27190099Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis.Ann Rheum Dis2017
28346068Institutional profile: University of Florida Health Personalized Medicine Program.Pharmacogenomics2017
29029330The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population.Rheumatology (Oxford)2017
28877912Type 1 Interferons Potentiate Human CD8<sup>+</sup> T-Cell Cytotoxicity Through a STAT4- and Granzyme B-Dependent Pathway.Diabetes2017
28586085Enrichment of IL-17A<sup>+</sup> IFN-γ<sup>+</sup> and IL-22<sup>+</sup> IFN-γ<sup>+</sup> T cell subsets is associated with reduction of NKp44<sup>+</sup> ILC3s in the terminal ileum of Crohn's disease patients.Clin Exp Immunol2017
28663145Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas.EBioMedicine2017
27889664Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis.Biomaterials2017
26735611Potent antigen-specific immune response induced by infusion of spleen cells coupled with succinimidyl-4-(N-maleimidomethyl cyclohexane)-1-carboxylate (SMCC) conjugated antigens.Int Immunopharmacol2016
26370400Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study.Rheumatology (Oxford)2016
27648464Restoring immune tolerance in neuromyelitis optica: Part II.Neurol Neuroimmunol Neuroinflamm2016
27648463Restoring immune tolerance in neuromyelitis optica: Part I.Neurol Neuroimmunol Neuroinflamm2016
27651910Systemic inflammatory responses in patients with type 2 diabetes with chronic periodontitis.BMJ Open Diabetes Res Care2016
27139508Discovery, Total Synthesis and Key Structural Elements for the Immunosuppressive Activity of Cocosolide, a Symmetrical Glycosylated Macrolide Dimer from Marine Cyanobacteria.Chemistry2016
27214679Micro and Nano Material Carriers for Immunomodulation.Am J Transplant2016
26985393A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation.J Mater Chem B2016
25039804Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes.Pediatr Diabetes2015
26385483Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression.Curr Diab Rep2015
26512207Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetes-prone Bicongenic B6.NODC11bxC1tb Mice.Genet Epigenet2015
25842187A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.Clin Immunol2015
25998290Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.Diabetes Care2015
24265024Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues.J Med Virol2014
26779386Characterization of Bone Marrow-Derived Dendritic Cells Developed in Serum-Free Media and their Ability to Prevent Type 1 Diabetes in Nonobese Diabetic Mice.J Blood Disord Transfus2014
24973447Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production.J Immunol2014
24778809Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres.J Mater Chem B2014
24835010C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2.PLoS One2014
24741590Anti-CD3 antibody treatment induces hypoglycemia and super tolerance to glucose challenge in mice through enhancing glucose consumption by activated lymphocytes.J Immunol Res2014
24616371Clinical pharmacogenetics implementation: approaches, successes, and challenges.Am J Med Genet C Semin Med Genet2014
24357690It's time to bring dendritic cell therapy to type 1 diabetes.Diabetes2014
24462356Integrin-directed modulation of macrophage responses to biomaterials.Biomaterials2014
24240437Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the Diabetes Autoimmunity Study in the Young.Diabetologia2014
23588301The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.Clin Pharmacol Ther2013
24204704Persistent STAT5 phosphorylation and epigenetic dysregulation of GM-CSF and PGS2/COX2 expression in Type 1 diabetic human monocytes.PLoS One2013
23611977Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes.Biol Blood Marrow Transplant2013
23651020Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.Pharmacogenomics2013
  • 1 - 50 of 143

Recommended Authors

Maigan A Brusko
University of Florida
Career Start Year 2017
Number of shared co-authors 6
Mark S Anderson
Diabetes Center, University of California san francisco
Career Start Year 2017
Number of shared co-authors 6
Thomas A Packard
J. David Gladstone Institutesgrid.249878.8
Career Start Year 2011
Number of shared co-authors 0
Ya??ma L Lightfoot
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 1
Cate Speake
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 2009
Number of shared co-authors 6
Alice E Wiedeman
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 2007
Number of shared co-authors 3
Kristina M Harris
University of California san francisco
Career Start Year 2006
Number of shared co-authors 3
Marc Veldhoen
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year 2005
Number of shared co-authors 0
Johnna D Wesley
Novo Nordisk Research Center Seattle, Inc.
Career Start Year 2003
Number of shared co-authors 2
Andrew Wang
Yale University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Sarah Alice Long
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1999
Number of shared co-authors 7
Francesca Fallarino
University of Perugia
Career Start Year 1995
Number of shared co-authors 0
PingAr Yang
University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Hui-Chen Hsu
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 0
Vivian H Gersuk
Center for Systems Immunology, Benaroya Research Institute
Career Start Year 1993
Number of shared co-authors 3
Chander Raman
University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
Qi Wu
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 0
Teresa P DiLorenzo
Universidad Cardenal Herrera-CEU, CEU Universities
Career Start Year 1989
Number of shared co-authors 0
Laura Santambrogio
Weill Cornell School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Ursula Grohmann
University of Perugia
Career Start Year 1988
Number of shared co-authors 0
Casey T Weaver
University of Alabama at Birmingham
Career Start Year 1986
Number of shared co-authors 0
Maura Rossetti
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Kevan C Herold
Yale University
Career Start Year 1983
Number of shared co-authors 5
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 1
John D Mountz
University of Alabama at Birmingham and Birmingham VA Medical Center.
Career Start Year 1978
Number of shared co-authors 1
Gerald T Nepom
Wash Benaroya Research Institute at Virginia Mason
Career Start Year 1975
Number of shared co-authors 4
Paola Ricciardi-Castagnoli
A. Menarini Biomarkers Singapore Pte Ltd
Career Start Year 1973
Number of shared co-authors 0
Merrill Eric Gershwin
Allergy and Clinical Immunology, University of California at Davis
Career Start Year 1967
Number of shared co-authors 0
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0

Collaborators

Lyle L Moldawer
University of Florida College of Medicine.
Co-authored papers 22
Clive Wasserfall
Co-authored papers 17
Jill M Norris
Co-authored papers 12
Todd M Brusko
College of Medicine, Diabetes Institute, University of Florida
Co-authored papers 9
Julie A Johnson
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 8
Philip O Scumpia
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 7
Philip A Efron
University of Florida Health
Co-authored papers 7
Amanda R Elsey
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 6
Ricardo Ungaro
University of Florida College of Medicine
Co-authored papers 6
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Co-authored papers 5
Drake Laface
Merck & Co. Inc.
Co-authored papers 5
Srikar Chamala
USC/Children's Hospital Los Angeles Los Angeles California USA.
Co-authored papers 4
Yi Li
Beth Israel Deaconess Hospital
Co-authored papers 4
Kristin W Weitzel
Department of Pharmacotherapy & Translational Research, University of Florida
Co-authored papers 4
Larisa H Cavallari
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 4
Ben Burkley
University of Florida College of Pharmacy Center for Pharmacogenomics
Co-authored papers 4
Donald M Smith
Georgetown University Medical Center
Co-authored papers 3
Matthew J Delano
University of Michigan ann arbor
Co-authored papers 3
Rhonda M Cooper-DeHoff
College of Medicine, University of Florida
Co-authored papers 3
Peter K Gregersen
Co-authored papers 3
David Nessl
Co-authored papers 3
Jeffrey P Krischer
Health Informatics Institute, University of South Florida
Co-authored papers 3
Jane H Buckner
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers 3
James L Wynn
University of Florida, College of Medicine
Co-authored papers 3
Kindra M Kelly-Scumpia
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 3
Kerri A O'Malley
Co-authored papers 3
Philip J Hess
Indiana University School of Medicine
Co-authored papers 2
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers 2
Tameka D Alestock
University of Maryland
Co-authored papers 2
Hui-Jia Dong
University of Florida College of Medicine
Co-authored papers 2
Release 1.2